JP2014237656A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014237656A5 JP2014237656A5 JP2014141096A JP2014141096A JP2014237656A5 JP 2014237656 A5 JP2014237656 A5 JP 2014237656A5 JP 2014141096 A JP2014141096 A JP 2014141096A JP 2014141096 A JP2014141096 A JP 2014141096A JP 2014237656 A5 JP2014237656 A5 JP 2014237656A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- drug
- composition
- compound
- drugs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *[C@]([C@@](CC#CC#CC1(*)*=*1)N=O)N Chemical compound *[C@]([C@@](CC#CC#CC1(*)*=*1)N=O)N 0.000 description 1
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9229108P | 2008-08-27 | 2008-08-27 | |
| US61/092,291 | 2008-08-27 | ||
| PCT/US2008/074444 WO2009105123A1 (en) | 2008-02-22 | 2008-08-27 | Compounds, compositions and methods for treating or preventing diseases |
| USUS08/74444 | 2008-08-27 | ||
| US12226808P | 2008-12-12 | 2008-12-12 | |
| US61/122,268 | 2008-12-12 | ||
| US22808309P | 2009-07-23 | 2009-07-23 | |
| US61/228,083 | 2009-07-23 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011525203A Division JP2012510953A (ja) | 2008-08-27 | 2009-08-27 | 毒性を減少し、そして疾病を治療又は予防するための化合物、組成物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014237656A JP2014237656A (ja) | 2014-12-18 |
| JP2014237656A5 true JP2014237656A5 (https=) | 2015-03-26 |
| JP5822991B2 JP5822991B2 (ja) | 2015-11-25 |
Family
ID=43971169
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011525203A Pending JP2012510953A (ja) | 2008-08-27 | 2009-08-27 | 毒性を減少し、そして疾病を治療又は予防するための化合物、組成物及び方法 |
| JP2014141096A Expired - Fee Related JP5822991B2 (ja) | 2008-08-27 | 2014-07-09 | 毒性を減少し、そして疾病を治療又は予防するための化合物、組成物及び方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011525203A Pending JP2012510953A (ja) | 2008-08-27 | 2009-08-27 | 毒性を減少し、そして疾病を治療又は予防するための化合物、組成物及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8859615B2 (https=) |
| EP (1) | EP2331093A4 (https=) |
| JP (2) | JP2012510953A (https=) |
| KR (1) | KR101496508B1 (https=) |
| CN (1) | CN102215840B (https=) |
| WO (1) | WO2010025272A1 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102146369A (zh) * | 2010-12-24 | 2011-08-10 | 吉林大学 | 一种基于配位作用的固相介质提取dna的方法 |
| CN102743795A (zh) * | 2012-05-11 | 2012-10-24 | 天津大学 | 虎杖甙填充胶原支架及其制备方法和应用 |
| WO2014089177A2 (en) | 2012-12-04 | 2014-06-12 | Massachusetts Institute Of Technology | Compounds, conjugates and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines |
| WO2014113635A1 (en) * | 2013-01-18 | 2014-07-24 | Sloan-Kettering Institute For Cancer Research | Reduction of toxicities by synthetic panaxytriol analogs |
| US9868730B2 (en) | 2013-02-18 | 2018-01-16 | The Trustees Of Columbia University In The City Of New York | Kappa opioid receptor selective compounds, compositions, and uses thereof |
| US10201623B2 (en) | 2013-03-15 | 2019-02-12 | Memorial Sloan Kettering Cancer Center | HSP90-targeted cardiac imaging and therapy |
| CA2961894C (en) | 2014-09-19 | 2023-12-12 | Memorial Sloan-Kettering Cancer Center | Methods for treating brain metastatis using gap junction inhibitors |
| US10918627B2 (en) | 2016-05-11 | 2021-02-16 | Massachusetts Institute Of Technology | Convergent and enantioselective total synthesis of Communesin analogs |
| CN106831366A (zh) * | 2017-01-20 | 2017-06-13 | 山西大学 | 一种共轭二炔一醇类化合物及其制备方法和应用 |
| CN106748827B (zh) * | 2017-01-20 | 2019-04-02 | 山西大学 | 一种8-胺基-4,6-二炔-1-醇类化合物及其制备方法和应用 |
| WO2018209239A1 (en) | 2017-05-11 | 2018-11-15 | Massachusetts Institute Of Technology | Potent agelastatin derivatives as modulators for cancer invasion and metastasis |
| US10640508B2 (en) | 2017-10-13 | 2020-05-05 | Massachusetts Institute Of Technology | Diazene directed modular synthesis of compounds with quaternary carbon centers |
| CN109704926B (zh) * | 2019-01-29 | 2022-02-08 | 南京工业大学 | 抗癌活性分子骨架1,4-烯炔类化合物及其制备方法与应用 |
| US11535634B2 (en) | 2019-06-05 | 2022-12-27 | Massachusetts Institute Of Technology | Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof |
| CN111467347A (zh) * | 2020-04-30 | 2020-07-31 | 河北医科大学第二医院 | 苯并菲啶生物碱类化合物用于制备ano1 编码的钙激活氯离子通道阻断剂的用途 |
| WO2022182415A1 (en) | 2021-02-24 | 2022-09-01 | Massachusetts Institute Of Technology | Himastatin derivatives, and processes of preparation thereof, and uses thereof |
| CN113372355B (zh) * | 2021-05-13 | 2023-02-17 | 山东大学 | 六氢苯并菲啶类生物碱及其制备方法和应用 |
| WO2023143988A1 (en) * | 2022-01-26 | 2023-08-03 | Eth Zurich | New compounds and their use as anti-aging agent or as exercise enhancer |
| CN120987853B (zh) * | 2025-07-22 | 2026-04-17 | 中国科学技术大学 | 一种NQO1响应性的mRNA翻译掩蔽剂及其应用、产品和方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07103024B2 (ja) * | 1986-03-07 | 1995-11-08 | 理化学研究所 | ジイン化合物を含む制癌剤 |
| JP2720176B2 (ja) * | 1988-09-08 | 1998-02-25 | 理化学研究所 | パナキサコール類の製造方法 |
| JPH03200736A (ja) * | 1989-12-28 | 1991-09-02 | Tsumura & Co | 新規ポリアセチレン系化合物類およびポリアセチレン系化合物類を有効成分とする抗腫瘍剤 |
| JPH05163202A (ja) * | 1991-02-26 | 1993-06-29 | Tsumura & Co | 新規ポリアセチレン系化合物類およびポリアセチレン系化合物類を有効成分とする５−リポキシゲナーゼ阻害剤 |
| CA2307393A1 (en) * | 2000-05-01 | 2001-11-01 | The University Of British Columbia | Ginsenoside chemotherapy |
| US20030092638A1 (en) * | 2001-09-21 | 2003-05-15 | Dong Huang | Protopanaxadiol and protopanaxatriol and their use as anti-cancer agents |
| US20070065526A1 (en) * | 2005-09-19 | 2007-03-22 | Gow Robert T | Methods and compositions comprising Panax species |
| US7419689B2 (en) * | 2005-11-15 | 2008-09-02 | Access Business Group International Llc. | Plant-based formulations for improving liver health |
-
2009
- 2009-08-27 JP JP2011525203A patent/JP2012510953A/ja active Pending
- 2009-08-27 KR KR1020117006139A patent/KR101496508B1/ko not_active Expired - Fee Related
- 2009-08-27 EP EP09810596.8A patent/EP2331093A4/en not_active Withdrawn
- 2009-08-27 WO PCT/US2009/055221 patent/WO2010025272A1/en not_active Ceased
- 2009-08-27 CN CN200980143766.2A patent/CN102215840B/zh not_active Expired - Fee Related
- 2009-08-27 US US13/061,508 patent/US8859615B2/en not_active Expired - Fee Related
-
2014
- 2014-07-09 JP JP2014141096A patent/JP5822991B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014237656A5 (https=) | ||
| Zafar et al. | Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy | |
| JP2012510953A5 (https=) | ||
| Jiao et al. | Disulfiram's anticancer activity: evidence and mechanisms | |
| KR102271848B1 (ko) | 암 치료용 약학적 배합물 | |
| US10183035B2 (en) | Etoposide and prodrugs thereof for use in targeting cancer stem cells | |
| CN101888777A (zh) | 用拓扑异构酶抑制剂和parp抑制剂的组合治疗癌症 | |
| Liu et al. | Sigma-2 receptor/TMEM97 agonist PB221 as an alternative drug for brain tumor | |
| US20210338686A1 (en) | Combination cancer therapy with pentaaza macrocyclic ring complex and platinum-based anticancer agent | |
| CN110769837A (zh) | 与五氮杂大环状环配合物的联合癌症免疫疗法 | |
| Mandegary et al. | Indomethacin‐enhanced anticancer effect of arsenic trioxide in A549 cell line: Involvement of apoptosis and phospho‐ERK and p38 MAPK pathways | |
| Cheong et al. | Enhanced autophagy in cytarabine arabinoside-resistant U937 leukemia cells and its potential as a target for overcoming resistance | |
| IL279609B1 (en) | Pyronaridine (pnd) for use in compositions for treating or preventing cancer | |
| JP2014512355A5 (https=) | ||
| CN1681489A (zh) | 增加抗肿瘤活性的化疗药物的联用 | |
| She et al. | Reprogramming energy metabolism with synthesized PDK inhibitors based on dichloroacetate derivatives and targeted delivery systems for enhanced cancer therapy | |
| Molinari et al. | AuNP pyrazolo [3, 4-d] pyrimidine nanosystem in combination with radiotherapy against glioblastoma | |
| JP2018501261A5 (https=) | ||
| US20170119895A1 (en) | Combination therapy comprising a liposomal prodrug of mitomycin c and radiotherapy | |
| ES2685612T3 (es) | Inhibidores de cinasa para el tratamiento del cáncer | |
| ES2430069T3 (es) | Dexanabinol con inhibidores del BRAF o la MEK para el tratamiento del melanoma | |
| US20250387406A1 (en) | Therapy for reduced ototoxicity from chemotherapeutic agent with pentaaza macrocyclic ring complex | |
| AU2015240775A1 (en) | Sigma-2 receptor ligand drug conjugates as antitumor compounds, methods of synthesis and uses thereof | |
| US20230158042A1 (en) | Combination cancer therapy with pentaaza macrocyclic ring complex and hormone therapy agent | |
| JP2023536389A (ja) | ペンタアザ大環状環複合体およびホルモン療法剤の併用がん治療法 |